Feraccru®

(ferric maltol)

Patient Information

Indication
Feraccru is indicated in adults for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD). The medicine can only be obtained with a prescription.

For further information on Ferracru please click below:

If you experience any side effects with Feraccru, talk to your doctor or nurse. This includes any side effects not listed in the patient information leaflet. You can also report side effects directly via the national reporting system: Yellow Card Scheme www.mhra.gov.uk/yellowcard

By reporting side effects, you can help provide more information on the safety of Feraccru. Always read the patient information leaflet provided with your medicine.

If you have a question or complaint about our products, or have experienced a side effect, please contact us.

London, UK

One Euston Square
40 Melton Street
London, NW1 2FD

t+44 (0) 207 186 8500

einfo@shieldtx.com

Newcastle, UK

Northern Design Centre
Baltic Business Quarter
Gateshead Quays, NE8 3DF

t+44 (0) 191 511 8500

einfo@shieldtx.com

Wollerau, Switzerland

Sihleggstrasse 23,
8832 Wollerau
Switzerland

t+41 (0) 435 080 781

einfo@shieldtx.com

Munich, Germany

München 5 Höfe
Theatinerstrasse 11
DE- 80333 München

t+49 (0) 892 444 23083

einfo.de@shieldtx.com